Status:
UNKNOWN
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
Lead Sponsor:
Hellenic Institute for the Study of Sepsis
Conditions:
COVID-19
Virus Diseases
Eligibility:
All Genders
18-110 years
Phase:
PHASE2
Brief Summary
The primary purpose is to describe the safety of administration of three doses of STS to critically ill patients with confirmed COVID-19. A secondary purpose is to describe data on the clinical effica...
Detailed Description
With the appearance of the COVID-19 pandemic, a race for the discovery of effective treatments to combat SARS-CoV-2 infection and its sequelae commenced. Some patients with COVID-19 develop severe acu...
Eligibility Criteria
Inclusion
- Age equal to or older than 18 years
- Both genders
- For women of childbearing potential, they must use or be willing to use a dual contraceptive method during the study.
- Written consent statement provided by the patient or his / her legal representative in case patients are unable to consent.
- Confirmed COVID-19 disease
- WHO-CPS 7 to 9
- Hospitalization in Intensive Care Unit
- Serum H2S levels less than 140 μM
Exclusion
- Age less than 18 years
- Denial of written consent
- Decision not to resuscitate
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05277285
Start Date
April 1 2022
End Date
December 31 2023
Last Update
January 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospitan of Athens KAT 2nd Department of ICU
Athens, Kifisia, Greece, 14561